pharma · Overweight and Obesity
Chengdu Di'ao Pharmaceutical
Chendu DIAO Pharmaceutical Group CO., LTD.
Chendu DIAO Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Overweight and Obesity. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(
Chengdu, CN HQ
7 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Chengdu, CN
- Employees
- 7
- Programs
- 1
- Drugs
- 0
- Patents
- 0
DA-302168S
Phase 2 · small molecule · Overweight and Obesity
DA-302168S for Overweight and Obesity is a Phase 2 program (small_molecule) at Chendu DIAO Pharmaceutical Group CO., LTD. with 1 ClinicalTrials.gov record(s).
Internal code 2024-CP-DA168-06
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chendu DIAO Pharmaceutical Group CO., LTD.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Overweight and Obesity
- Status
- active
- Trials
- 1